T. Rowe Price Associates’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $54.1M | Buy |
|
|||||
|
2021
Q2 | $74M | Buy |
|
|||||
|
2021
Q1 | $43.3M | Sell |
|
|||||
|
2020
Q4 | $45.7M | Sell |
|
|||||
|
2020
Q3 | $37.7M | Sell |
|
|||||
|
2020
Q2 | $60.8M | Sell |
|
|||||
|
2020
Q1 | $48.3M | Sell |
|
|||||
|
2019
Q4 | $72.3M | Buy |
|
|||||
|
2019
Q3 | $18.3M | Buy |
|
|||||
|
2019
Q2 | $18.2M | Buy |
|
|||||
|
2019
Q1 | $10.9M | Buy |
|
|||||
|
2018
Q4 | $3.56M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $799K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $4.88M | Buy |
|